Chad Hamilton to Neoplasm Staging
This is a "connection" page, showing publications Chad Hamilton has written about Neoplasm Staging.
Connection Strength
0.803
-
The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study. Gynecol Oncol. 2011 Sep; 122(3):521-6.
Score: 0.085
-
The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma. Gynecol Oncol. 2006 Nov; 103(2):679-83.
Score: 0.060
-
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer. 2006 Mar 13; 94(5):642-6.
Score: 0.059
-
Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys. 2005 Nov 01; 63(3):839-44.
Score: 0.058
-
Factors Associated With Survival Disparities Between Non-Hispanic Black and White Patients With Uterine Cancer. JAMA Netw Open. 2023 04 03; 6(4):e238437.
Score: 0.048
-
Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning. Gynecol Oncol. 2022 07; 166(1):90-99.
Score: 0.046
-
Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival. Gynecol Oncol. 2020 04; 157(1):67-77.
Score: 0.039
-
Impact of adjuvant treatment and prognostic factors in stage I uterine leiomyosarcoma patients treated in Commission on Cancer?-accredited facilities. Gynecol Oncol. 2020 04; 157(1):121-130.
Score: 0.039
-
Racial disparities in molecular subtypes of endometrial cancer. Gynecol Oncol. 2018 04; 149(1):106-116.
Score: 0.034
-
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2018 06; 149(3):525-530.
Score: 0.034
-
Relative Effects of Age, Race, and Stage on Mortality in Gestational Choriocarcinoma. Int J Gynecol Cancer. 2018 02; 28(2):338-345.
Score: 0.034
-
Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study. Gynecol Oncol. 2018 01; 148(1):49-55.
Score: 0.033
-
Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients. Cancer. 2017 Oct 15; 123(20):4004-4012.
Score: 0.032
-
Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line. Hum Cell. 2017 Jul; 30(3):226-236.
Score: 0.032
-
What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study. Cancer. 2017 May 15; 123(6):985-993.
Score: 0.031
-
Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis. Gynecol Oncol. 2016 Dec; 143(3):460-465.
Score: 0.031
-
Nestin: A biomarker of aggressive uterine cancers. Gynecol Oncol. 2016 Mar; 140(3):503-11.
Score: 0.029
-
Transcript expression in endometrial cancers from Black and White patients. Gynecol Oncol. 2013 Jul; 130(1):169-73.
Score: 0.024
-
Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Jan; 124(1):53-8.
Score: 0.022
-
Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy? Cancer. 2008 Sep 15; 113(6):1431-7.
Score: 0.018
-
Outcomes of women with metachronous breast and ovarian carcinomas. Gynecol Oncol. 2006 Oct; 103(1):190-4.
Score: 0.015